Published and available for citation: Warner K, See W, Haerry D, Klingmann I, Hunter A and May M (2018) EUPATI Guidance for Patient Involvement in Medicines Research and Development...
Introduction An R&D collaboration between the European AIDS Treatment Group, European Liver Patients Association, Treatment Action Group, and Janssen R&D. Description of the case Patients were involved as follows:...
Introduction This is a collaboration between Bristol-Myers Squibb (BMS) with FUNDHEPA (patient organisation) to give more patients the opportunity to receive an innovative treatment for Hepatitis C through the...
Transcript My name is Matthew May. I work for DIA, which is a non-profit in the pharmaceutical industry. We’re a global membership association who also provide conferences and...
As utilisation of digital technologies in healthcare systems is expanding, more and more data are being collected. Organisation and integration of the collected data from different sources, called...
Once a target receptor molecule or an enzyme has been identified, scientists begin to look for potential compounds that will interact with the target to correct disease-related activity.These molecules...
There are several types of clinical trial designs: randomised or non-randomised controlled trials, single or double blinded trials, and superiority or non-inferiority trials.
Risk management is important in medicines development and pharmacovigilance in order to avoid crisis situations and harmful consequences. There are various kinds of risk; risk management strategies must assess...
Off-label use of a medicine is the use of an authorised medicine by a healthcare professional to treat a patient in a way not covered by the Marketing Authorisation...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
